Lin, Hongyan
Tang, Yun
Zhou, Shibin
Huang, Wei
Hu, Ling
Jin, Liang
Funding for this research was provided by:
Leshan City Science and Technology Bureau key research project (Grant No. 22SZD041)
Leshan City Science and Technology Bureau key research project (Grant No. 22SZD041)
Leshan City Science and Technology Bureau key research project (Grant No. 22SZD041)
Leshan City Science and Technology Bureau key research project (Grant No. 22SZD041)
Leshan City Science and Technology Bureau key research project (Grant No. 22SZD041)
Leshan City Science and Technology Bureau key research project (Grant No. 22SZD041)
Article History
Received: 29 August 2024
Accepted: 15 November 2025
First Online: 26 November 2025
Declarations
:
: This study was approved by the Ethics Committee of the People’s Hospital of Leshan [LYLL [2024] KY 012]. The trial was registered at the Chinese Clinical Trial Center on April 24, 2024. The registration number of this study is ChiCTR2400083410. The requirement for written informed patient consent was waived due to the retrospective nature of the study, which involved no more than minimal risk, and the information used in the study was anonymized. The Research Ethics Committee of the Faculty of Medicine and the Ethics Committee of the People’s Hospital of Leshan waived the need for informed consent.
: Not applicable.
: The authors declare no competing interests.